1. Home
  2. Stocks
  3. Rossari Share Price

Rossari Biotech Share Price

Chemicals Small Cap

₹800.55 +2.85 (0.36%)

05 Nov, 2024 16:51

SIP TrendupStart SIP in ROSSARI

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹790
  • High
  • ₹803
  • 52 Week Low
  • ₹657
  • 52 Week High
  • ₹973
  • Open Price₹790
  • Previous Close₹798
  • Volume21,324

Investment Returns

  • Over 1 Month -8.69%
  • Over 3 Month -11.89%
  • Over 6 Month + 10.05%
  • Over 1 Year + 12.02%
SIP Lightning

Smart Investing Starts Here Start SIP with Rossari Biotech for Steady Growth!

Rossari Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.9
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 4,432
  • P/B Ratio
  • 4.2
  • Average True Range
  • 28.51
  • EPS
  • 17.6
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -24.9
  • RSI
  • 40.11
  • MFI
  • 39.75

Rossari Biotech Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations335.99300.71313.80298.75332.01
Total Income From Operations335.99300.71313.80298.75332.01
P/L Before Interest, Excpt. Items & Tax38.8135.0036.4837.4338.04
P/L Before Exceptional Items & Tax36.9132.6734.7534.8035.50
P/L After Tax from Ordinary Activities27.4224.3326.1725.5426.38
Net Profit/Loss For the Period27.4224.3326.1725.5426.38
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,188.80969.20
Revenue From Operations [Net]1,188.80969.20
Total Operating Revenues1,202.91975.17
Total Revenue1,209.68978.77
Total Expenses1,075.55883.13
Profit/Loss Before Tax134.1395.65
Profit/Loss For The Period99.6571.39
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity73.92113.66
Net Cash Used In Investing Activity-69.55-160.59
Net Cash Used in Finance Activity-22.0961.21
Net Inc/Dec In Cash And Equivalent-17.9514.28
Cash And Equivalent End Of Year22.5541.02
IndicatorMar 24Mar 23
Total Share Capital11.0511.03
Total Non-Current Liabilities37.6937.06
Total Current Liabilities283.14229.91
Total Capital And Liabilities1,281.171,125.67
Total Non-Current Assets713.19655.00
Total Current Assets567.98470.67
Total Assets1,281.171,125.67
Indicator20242023
EBIT Margin (%)11.9510.28
Return On Capital Employed (%)14.4111.19
Return On Equity (%)10.378.31
Long Term Debt To Equity (%)2.594.06
Book Value/Share (INR)173.83155.69
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations498.35489.65472.72463.77483.47
Total Income From Operations498.35489.65472.72463.77483.47
P/L Before Interest, Excpt. Items & Tax51.5050.4647.9152.0849.82
P/L Before Exceptional Items & Tax47.8246.7845.3947.7644.79
P/L After Tax from Ordinary Activities35.0434.6933.9534.3732.93
Net Profit/Loss For the Period35.0434.6933.9534.3732.93
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,830.561,651.32
Revenue From Operations [Net]1,830.561,651.32
Total Operating Revenues1,830.561,655.88
Total Revenue1,838.001,661.37
Total Expenses1,660.561,518.10
Profit/Loss Before Tax177.44143.26
Profit/Loss For The Period130.51106.30
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity43.26152.39
Net Cash Used In Investing Activity-103.21-180.89
Net Cash Used in Finance Activity16.1960.86
Net Inc/Dec In Cash And Equivalent-44.0332.36
Cash And Equivalent End Of Year25.1769.83
IndicatorMar 24Mar 23
Total Share Capital11.0511.03
Total Non-Current Liabilities99.69105.54
Total Current Liabilities424.74346.86
Total Capital And Liabilities1,572.151,367.57
Total Non-Current Assets727.37646.41
Total Current Assets844.79721.16
Total Assets1,572.151,367.57
Indicator20242023
EBIT Margin (%)10.759.99
Return On Capital Employed (%)17.1516.22
Return On Equity (%)12.4711.71
Long Term Debt To Equity (%)3.183.81
Book Value/Share (INR)189.65165.93

Rossari Biotech Technicals

EMA & SMA

Current Price
₹800.55
+ 2.85 (0.36%)
pointer
  • stock-down_img
  • Bullish Moving Average 4
  • stock-up_img
  • Bearish Moving Average 12
  • 20 Day
  • ₹821.82
  • 50 Day
  • ₹848.09
  • 100 Day
  • ₹840.69
  • 200 Day
  • ₹818.51

Resistance and Support

802.55 Pivot Speed
  • R3 842.05
  • R2 830.50
  • R1 814.10
  • S1 786.15
  • S2 774.60
  • S3 758.20

Is Rossari Biotech Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Rossari Biotech is a leading specialty chemicals manufacturer in India, offering solutions across home and personal care, performance chemicals, and textile specialty chemicals. With three manufacturing plants, it serves clients in over 25 countries with sustainable chemical solutions. Rossari Biotech has an operating revenue of Rs. 1,924.48 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 67 which is a FAIR score but needs to improve its earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 59 indicates it belongs to a fair industry group of Diversified Operations and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Rossari Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-19 Quarterly Results
2024-07-20 Quarterly Results
2024-04-29 Audited Results & Final Dividend
2024-01-20 Quarterly Results
2023-10-21 Quarterly Results

Rossari Biotech F&O

Rossari Biotech Shareholding Pattern

68.27%
13.18%
4.05%
3.74%
0%
9.56%
1.2%
  • NSE Symbol
  • ROSSARI
  • BSE Symbol
  • 543213
  • Managing Director
  • Mr. Sunil Chari
  • ISIN
  • INE02A801020

Rossari Biotech FAQs

Rossari Biotech share price is ₹800 As on 05 November, 2024 | 16:37

The Market Cap of Rossari Biotech is ₹4431.5 Cr As on 05 November, 2024 | 16:37

The P/E ratio of Rossari Biotech is 31.9 As on 05 November, 2024 | 16:37

The PB ratio of Rossari Biotech is 4.2 As on 05 November, 2024 | 16:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.